Weekly Recap

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

May 08, 2021

Neurology News Network for the week ending May 8, 2021.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

May 01, 2021

Neurology News Network for the week ending May 1, 2021.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

April 24, 2021

Neurology News Network for the week ending April 24, 2021.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

April 17, 2021

Neurology News Network for the week ending April 17, 2021.

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

April 10, 2021

Neurology News Network for the week ending April 10, 2021.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

April 03, 2021

Neurology News Network for the week ending April 3, 2021.

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

March 27, 2021

Neurology News Network for the week ending March 27, 2021.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

March 20, 2021

Neurology News Network for the week ending March 20, 2021.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

March 13, 2021

Neurology News Network for the week ending March 13, 2021.

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

March 06, 2021

Neurology News Network for the week ending March 6, 2021.